Kiley Juergens Wealth Management’s AbbVie ABBV Stock Holding History

Kiley Juergens Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.83M	Sell	7,258 -37	-0.5%	-$7.96K	0.29%	69
2026 Q1	$1.59M	Buy	+7,295	New	+$1.62M	0.28%	65
2023 Q4	–	Sell	-10,030	Closed	-$1.5M	–	66
2023 Q3	$1.5M	Sell	10,030 -1,344	-12%	-$197K	0.54%	36
2023 Q2	$1.53M	Sell	11,374 -2,395	-17%	-$351K	0.53%	35
2023 Q1	$2.19M	Buy	13,769 +144	+1%	+$22K	0.82%	31
2022 Q4	$2.2M	Sell	13,625 -91	-0.7%	-$14K	0.92%	26
2022 Q3	$1.84M	Buy	13,716 +10	+0.1%	+$1.44K	0.87%	28
2022 Q2	$2.1M	Buy	+13,706	New	+$2.09M	0.99%	24
2022 Q1	–	Sell	-13,970	Closed	-$1.89M	–	53
2021 Q4	$1.89M	Buy	13,970 +1,904	+16%	+$225K	0.72%	28
2021 Q3	$1.3M	Buy	+12,066	New	+$1.38M	0.57%	34
2018 Q4	–	Sell	-1,761	Closed	-$166K	–	41
2018 Q3	$166K	Buy	1,761 +721	+69%	+$68.4K	0.12%	113
2018 Q2	$96K	Buy	+1,040	New	+$102K	0.09%	137
2018 Q1	–	Sell	-1,055	Closed	-$102K	–	84
2017 Q4	$102K	Buy	+1,055	New	+$99.4K	0.09%	128

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Kiley Juergens Wealth Management's ABBV Position: Q2 2026 in Review

Kiley Juergens Wealth Management reduced its AbbVie (ABBV) stake by 0.51% in Q2 2026, selling an estimated $7.96K and leaving 7,258 shares worth $1.83M. The position accounts for 0.29% of the portfolio, ranked #69.

Kiley Juergens Wealth Management first reported a position in ABBV in Q4 2017 and has held it in 13 quarters since. The position peaked at $2.2M in Q4 2022. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Kiley Juergens Wealth Management held 7,258 shares of AbbVie worth $1.83M as of Q2 2026.
Kiley Juergens Wealth Management sold 37 AbbVie shares in Q2 2026, an estimated $7.96K.
AbbVie made up 0.29% of Kiley Juergens Wealth Management's portfolio in Q2 2026, its #69 holding.
Kiley Juergens Wealth Management first reported a position in AbbVie in Q4 2017 and has held it in 13 quarters since.
Kiley Juergens Wealth Management's AbbVie position peaked at $2.2M in Q4 2022.
4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Kiley Juergens Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.